You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Correction: Functional analysis of BRCA1 M1628V variant
  1. Marcelo A Carvalho,
  2. Alvaro N A Monteiro
  1. Department of Risk Assessment, Detection, and Intervention, H Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA
  1. Correspondence to:
 Associate Professor A N A Monteiro
 H Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA;monteian{at}moffitt.usf.edu

https://doi.org/10.1136/jmg.2006.045344

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Germline-inactivating mutations in the breast and ovarian cancer susceptibility gene BRCA1 are associated with a substantial increase in the risk of cancer.1 One of the possible outcomes of genetic testing for BRCA1 is the finding of an alteration in the BRCA1 coding region for which the risk of cancer has not been determined. These alterations have been termed unclassified variants (UCVs) or variants of uncertain significance. Most of these alterations are missense changes (Breast Cancer Information Core database, http://research.nhgri.nih.gov/bic/). We have developed a functional assay that aids in the determination of the association of cancer with BRCA1 UCVs.2,3 The assay measures the …

    View Full Text